| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director, 10% Owner
1 company
Lettmann Jason is a Chief Executive Officer at ALX ONCOLOGY HOLDINGS INC. Recent SEC Form 4 filings include 5 buys and 30 sells.
Estimated insider holdings value: $572K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2025 | ALXO Alx Oncology Holdings Inc | Chief Executive Officer | Buy | 92,233 | $1.08 | $99,352.24 | +20.6% | +36.2% | - | |
| Aug 15, 2025 | ALXO Alx Oncology Holdings Inc | Chief Executive Officer | Sell | 2,382 | $0.64 | $1,525.43 | -1.1% | +89.4% | - | |
| Feb 19, 2025 | ALXO Alx Oncology Holdings Inc | Chief Executive Officer | Sell | 2,159 | $1.15 | $2,483.28 | -1.3% | -64.0% | +118.5% | |
| Mar 14, 2024 | ALXO Alx Oncology Holdings Inc | Chief Executive Officer | Buy | 4,400 | $11.31 | $49,771.48 | +2.6% | -23.5% | -92.6% | |
| Dec 13, 2021 | ALXO Alx Oncology Holdings Inc | Director, 10% Owner | Sell | 325,377 | $27.36 | $8,901,803.95 | -2.2% | -33.0% | -51.4% | |
| Dec 10, 2021 | ALXO Alx Oncology Holdings Inc | Director, 10% Owner | Sell | 145,637 | $32.26 | $4,698,091.14 | -0.7% | -39.9% | -65.4% | |
| Jul 21, 2020 | ALXO Alx Oncology Holdings Inc | Director, 10% Owner | Buy | 400,000 | $19.00 | $7,600,000.00 | New | - | - |